Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,335 | 350 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $793.42 | 40 | $0 (2024) |
| ITI, Inc. | $764.60 | 37 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $707.60 | 32 | $0 (2024) |
| ABBVIE INC. | $689.80 | 56 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $559.12 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $531.73 | 26 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $481.33 | 28 | $0 (2024) |
| Alkermes, Inc. | $477.61 | 26 | $0 (2024) |
| Lundbeck LLC | $364.64 | 17 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $201.94 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,004 | 107 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($481.33) |
| 2023 | $1,412 | 74 | ITI, Inc. ($389.15) |
| 2022 | $1,582 | 94 | Alkermes, Inc. ($302.43) |
| 2021 | $1,337 | 75 | Takeda Pharmaceuticals U.S.A., Inc. ($365.06) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ADHD | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $37.76 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/28/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/03/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: ADHD | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 88 | $9,986 | $5,167 |
| 2022 | 3 | 59 | 84 | $8,075 | $4,286 |
| 2021 | 1 | 29 | 77 | $6,930 | $3,724 |
| 2020 | 1 | 11 | 37 | $3,330 | $1,182 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 62 | $7,750 | $4,101 | 52.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 26 | $2,236 | $1,066 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 46 | $4,070 | $1,961 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 21 | $2,575 | $1,543 | 59.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 11 | 17 | $1,430 | $781.41 | 54.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 77 | $6,930 | $3,724 | 53.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 37 | $3,330 | $1,182 | 35.5% |
About Robert Crowell, CRNP
Robert Crowell, CRNP is a Psychiatric/Mental Health healthcare provider based in Helena, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1386110468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Crowell, CRNP has received a total of $6,335 in payments from pharmaceutical and medical device companies, with $2,004 received in 2024. These payments were reported across 350 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,335).
As a Medicare-enrolled provider, Crowell has provided services to 126 Medicare beneficiaries, totaling 286 services with total Medicare billing of $14,359. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Helena, AL
- Active Since 10/16/2018
- Last Updated 10/22/2018
- Taxonomy Code 163WP0808X
- Entity Type Individual
- NPI Number 1386110468
Products in Payments
- CAPLYTA (Drug) $1,246
- REXULTI (Drug) $858.77
- TRINTELLIX (Drug) $707.60
- VRAYLAR (Drug) $689.80
- Qelbree (Drug) $459.91
- ARISTADA (Drug) $438.11
- SPRAVATO (Drug) $412.19
- QELBREE (Drug) $333.51
- FANAPT (Drug) $168.03
- INVEGA SUSTENNA (Drug) $119.54
- LATUDA (Drug) $106.66
- Auvelity (Drug) $90.09
- Dyanavel XR (Drug) $82.09
- INGREZZA (Drug) $81.25
- Azstarys (Drug) $77.05
- AZSTARYS (Drug) $51.53
- ABILIFY MAINTENA (Drug) $47.27
- AUSTEDO (Drug) $43.12
- LYBALVI (Drug) $39.50
- Xelstrym (Drug) $37.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Helena
Mr. Jeffrey Edelman, Np, NP
Psychiatric/Mental Health — Payments: $53,391
Anthony Phillips, Crnp, CRNP
Psychiatric/Mental Health — Payments: $11,464
Logan Mendheim
Psychiatric/Mental Health — Payments: $9,683
Tara Wells, Fnp-C, Pmhnp-C, FNP-C, PMHNP-C
Psychiatric/Mental Health — Payments: $8,264
Ms. Rachel Hutchinson, Crnp, CRNP
Psychiatric/Mental Health — Payments: $1,165
Emily Michalski-Weber, Aprn, APRN
Psychiatric/Mental Health — Payments: $469.17